Biogen (BIIB)

Other Income/Expenses (Net)

-$185.70M

Quarterly · Period ending: · USD

BIIB logo

BIIB Other Income/Expenses (Net)

Latest reported-$185.70M
BIIB Quarterly Other Income/Expenses (Net) (-$4.00M → -$185.70M)
High-resolution chart · PNG

BIIB other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-185,700,000
-19,700,000
-154,000,000
-56,500,000
155,900,000
-421,400,000
-217,500,000
-126,200,000
332,200,000
-225,600,000
-220,800,000
-462,000,000
18,400,000
-136,100,000
45,500,000
501,100,000
339,000,000
-180,300,000
-84,200,000
-507,400,000
145,600,000
-525,100,000
701,500,000
-141,700,000
78,100,000
-135,300,000
-61,900,000
-49,100,000
-213,700,000
328,600,000
-28,600,000
115,100,000
-34,500,000
-41,000,000
-66,400,000
-44,000,000
-68,600,000
-38,000,000
-48,000,000
-58,100,000
-58,500,000
-52,800,000
-82,400,000
-22,200,000
-15,800,000
-15,900,000
-8,938,000
-21,684,000
2,928,000
-13,206,000
-10,359,000
-10,810,000
-2,235,000
-15,494,000
-5,595,000
15,654,000
2,950,000
15,144,000
-3,973,000
-7,727,000
-11,728,000
9,951,000
-4,665,000
-6,945,000
1,012,000
-8,386,000
6,366,000
9,360,000
14,680,000
6,846,000
-34,850,000
-23,713,000
-4,018,000
3,080,000
32,631,000
44,904,000
31,586,000
21,702,000
-10,647,000
22,319,000
21,806,000
18,665,000
11,837,000
11,192,000
6,051,000
-8,926,000
4,111,000
-1,573,000
6,413,000
11,726,000
-23,511,000
1,986,000
3,253,000
3,310,000
-24,715,000
-10,459,000
8,104,000
7,028,000
-8,844,000
10,147,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.